Wolters, RJ; Bej, AJ; Tanner, NS. Conformationally constrained analogs of mescaline J. Pharm. Sci., 1 Jan 1974, 63 (1), 1379–1382. 451 kB. https://doi.org/10.1002/jps.2600630909 #IX NMR
Nichols, DE. Structure-activity relationships of phenethylamine hallucinogens J. Pharm. Sci., 1 Aug 1981, 70 (8), 839–849. 1.4 MB. https://doi.org/10.1002/jps.2600700802 #XLII
CPM · Cyclopropylmescaline
3C-AL · 4-Allyloxy-3,5-dimethoxyamphetamine
2,5-Dimethoxy-4-propanonylamphetamine · DOCOE
N-AL-M · N-Allyl-3,4,5-trimethoxyphenethylamine
N-Cyclopropyl-3,4,5-trimethoxyphenethylamine · N-cPr-M
4-(1-Methylallyloxy)-3,5-dimethoxyphenethylamine · sec-MAL · sec-Methallylescaline · MAL-2
4-Methallyloxy-2,6-dimethoxyphenethylamine · ψ-2C-O-3
4-Allyloxy-2,6-dimethoxyamphetamine · ψ-MALM
2,5-Dimethoxy-4-methallyloxyphenethylamine · 2C-O-3
4-Allyloxy-2,5-dimethoxyamphetamine · MALM
2C-THF3 · 4-(Tetrahydrofuran-3-yl)-2,5-dimethoxyphenethylamine
2C-THF2 · 4-(Tetrahydrofuran-2-yl)-2,5-dimethoxyphenethylamine
3-Methoxy-4-propoxymethcathinone · POMMC
N-Acetyl-2,5-dimethoxy-4-methylamphetamine · N-Acetyl-DOM